Strategic partnerships VOZ Advisors specializes in enabling partnerships between pharmaceutical/biotech developers and patient advocacy, market research, and policy groups. This positions them to connect clients with insights on patient experiences, payer preferences, and regulatory considerations to accelerate development and commercialization.

Patient-centric focus With a mission centered on patient experience driving product development, VOZ can offer consulting services to health tech and pharma firms seeking to enhance patient engagement strategies, real-world evidence generation, and outcomes research that resonates with stakeholders and payers.

Leadership and credibility Executive leadership changes and industry positions (e.g., President/CEO appointment and Entrepreneur in Residence) suggest strong network access and credibility. This can be leveraged to win projects related to thought leadership, stakeholder engagement programs, and strategic advisory for market access.

Strategic partnerships pipeline Recent collaboration with Takeda indicates VOZ’s capability to execute global, stigma-focused patient insights. This signals opportunities to pitch global patient-centric studies, brand strategy consulting, and multi-country market access programs for large pharma.

Growth opportunity profile Revenue in the mid-range of tens of millions and a lean team suggests VOZ is scalable for smaller, high-value engagements as well as broader programs. This aligns with offering modular services such as rapid diagnostic research sprints, advocacy mapping, and targeted payer/HEOR support to expand wallet share.